Labeling mistakes that get missed on first submission

The EU: exact wording, not "close enough"

A supplement brand had its French distribution stalled last year — not because of a failed safety test or an expired GMP certificate, but because of three words on the front panel: "supports heart health." Under Regulation (EC) No 1924/2006, EU health claims must appear, word for word or close enough to satisfy the relevant authority, on the official EU Register of authorised health claims. If a claim isn't on that Register, it isn't legal to use — no matter how well-established or scientifically reasonable it sounds. Brands coming from the US market especially misjudge this, because the American structure/function claim framework (where "supports immune function" is broadly acceptable) doesn't work the same way in the EU. Citing an EFSA scientific opinion as your basis for a claim is also a common — and incorrect — assumption; an EFSA opinion is scientific input to the Commission's decision, not approval in itself.

The US: the disclaimer has to be linked to the claim

Under DSHEA and 21 CFR Part 101, any structure/function claim on a US supplement label requires the standard disclaimer, worded and linked to that specific claim as the regulation prescribes — and a missing or unlinked disclaimer is consistently the most common finding in FDA warning letters on supplement labels. Note also: as of a December 2025 FDA letter to industry, the agency is exercising enforcement discretion on requiring the disclaimer to repeat on every single panel where a claim appears, though the underlying requirement to include and link it hasn't gone away — worth confirming current status before assuming either the old or the relaxed reading applies to your label. Separately, dietary ingredients must be ordered by descending weight within their blend, not by an arbitrary or marketing-driven order — inspectors check this specifically.

Australia: it's not filed as a "supplement" at all

The most consequential mistake for Australia happens before the label is even designed: assuming the product will be classified as a food-category supplement the way it might be in India or the US. In Australia, these products are regulated as complementary medicines, entered in the Australian Register of Therapeutic Goods (ARTG) with an AUST L, AUST L(A), or AUST R number that must appear on the front label. The permitted therapeutic indications must be selected from TGA's pre-approved list, and the sponsor must hold evidence supporting them even though the TGA doesn't pre-vet listed medicines before market entry. Post-market compliance reviews are real and active — TGA has flagged supplements where actual potency didn't match the labeled amount, which is exactly the kind of gap a proper formulation and testing review catches before it becomes a compliance action.

The GCC: bilingual labeling and the claims line that changes your product's category

We covered UAE market entry requirements in a separate article, but on labeling specifically: every mandatory element — brand, ingredients, origin, manufacturer, batch, weight, expiry, barcode — must appear in both Arabic and English, and the line between a structure/function claim and a disease-treatment claim is the same line that quietly moves a product out of the supplement pathway and into the much heavier pharmaceutical one.

India: the claim has to be backed before the label is printed, not after

Under FSSAI's nutraceutical framework, the most common labeling-stage rejection isn't a formatting issue — it's a health claim that doesn't have credible scientific substantiation behind it at the point of filing. The same applies to ingredients: every active must sit within its permitted dosage range on the current list, not just be present on it. We covered the licensing side of this separately in our FSSAI licensing article.

The pattern across all five

Every one of these is a claims-and-evidence problem wearing a labeling disguise. The fix is the same in every market: settle what you can actually claim, and confirm you can prove it, before the label goes anywhere near a printer.